Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tehila Kharizman"'
Autor:
Eyal Klang, Marianne M. Amitai, Philip Lawson, Shelly Soffer, Raanan Berger, Tehila Kharizman, Eli Konen, Stephen Raskin, Edith M. Marom
Publikováno v:
Br J Radiol
Objectives: We aimed to analyze the association between the onsets of PE and of progressive disease (PD) in CT scans of oncological patients undergoing clinical trials. Methods: We retrospectively searched our oncological clinical trials database (1/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcce4d2545d27bcf245c488c3949550e
https://pubmed.ncbi.nlm.nih.gov/32816525
https://pubmed.ncbi.nlm.nih.gov/32816525
Autor:
Stephen Raskin, Eli Konen, Michal Amitai, Tatyana Rachutin Zalogin, Raanan Berger, Tehila Kharizman, Aliza Ackerstein
Publikováno v:
Journal of Clinical Oncology. 38:e14149-e14149
e14149 Background: Oncologists often need an objective, quantitative assessment of a patient's response to therapy. Lacking a standardized format, the oncologist may request a RECIST (Response Evaluation Criteria in Solid Tumors) analysis. RECIST, ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3934a2139e1726a54f268152b810d47
https://doi.org/10.1200/jco.2020.38.15_suppl.e14149
https://doi.org/10.1200/jco.2020.38.15_suppl.e14149
Publikováno v:
Journal of Clinical Oncology. 37:e18053-e18053
e18053 Background: RECIST, among methodologies designed to provide an objective assessment of tumor response to therapy, is based on the measurement of Target Lesions (TLs) and classification of response according to an objective scale of beneficial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14c52350558e645cb5768dab6dd51f33
https://doi.org/10.1200/jco.2019.37.15_suppl.e18053
https://doi.org/10.1200/jco.2019.37.15_suppl.e18053